Influenza vaccine effectiveness in older adults compared with younger adults over five seasons
Journal Title: | Vaccine 2018-02-28, Vol.36 (10), p.1272-1278 |
Main Author: | Russell, Kate |
Other Authors: | Chung, Jessie R , Monto, Arnold S , Martin, Emily T , Belongia, Edward A , McLean, Huong Q , Gaglani, Manjusha , Murthy, Kempapura , Zimmerman, Richard K , Nowalk, Mary Patricia , Jackson, Michael L , Jackson, Lisa A , Flannery, Brendan |
Format: |
![]() |
Language: |
English |
Subjects: | |
Quelle: | Alma/SFX Local Collection |
Publisher: | Netherlands: Elsevier Ltd |
ID: | ISSN: 0264-410X |
Link: | https://www.ncbi.nlm.nih.gov/pubmed/29402578 |
Zum Text: |
SendSend as email
Add to Book BagAdd to Book Bag
Staff View

recordid: | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5812289 |
title: | Influenza vaccine effectiveness in older adults compared with younger adults over five seasons |
format: | Article |
creator: |
|
subjects: |
|
ispartof: | Vaccine, 2018-02-28, Vol.36 (10), p.1272-1278 |
description: | There have been inconsistent reports of decreased vaccine effectiveness (VE) against influenza viruses among older adults (aged ≥ 65 years) compared with younger adults in the United States. A direct comparison of VE over multiple seasons is needed to assess the consistency of these observations. We performed a pooled analysis of VE over 5 seasons among adults aged ≥ 18 years who were systematically enrolled in the U.S. Flu VE Network. Outpatients with medically-attended acute respiratory illness (cough with illness onset ≤ 7 days prior to enrollment) were tested for influenza by reverse transcription polymerase chain reaction. We compared differences in VE and vaccine failures among older adult age group (65–74, ≥75, and ≥ 65 years) to adults aged 18–49 years by influenza type and subtype using interaction terms to test for statistical significance and stratified by prior season vaccination status. Analysis included 20,022 adults aged ≥ 18 years enrolled during the 2011–12 through 2015–16 influenza seasons; 4,785 (24%) tested positive for influenza. VE among patients aged ≥ 65 years was not significantly lower than VE among patients aged 18–49 years against any subtype with no significant interaction of age and vaccination. VE against A(H3N2) viruses was 14% (95% confidence interval [CI] −14% to 36%) for adults ≥ 65 years and 21% (CI 9–32%) for adults 18–49 years. VE against A(H1N1)pdm09 was 49% (95% CI 22–66%) for adults ≥ 65 years and 48% (95% CI 41–54%) for adults 18–49 years and against B viruses was 62% (95% CI 44–74%) for adults ≥ 65 years and 55% (95% CI 45–63%) for adults 18–49 years. There was no significant interaction of age and vaccination for separate strata of prior vaccination status. Over 5 seasons, influenza vaccination provided similar levels of protection among older and younger adults, with lower levels of protection against influenza A(H3N2) in all ages. |
language: | eng |
source: | Alma/SFX Local Collection |
identifier: | ISSN: 0264-410X |
fulltext: | fulltext |
issn: |
|
url: | Link |
@attributes |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PrimoNMBib |
|